Stability and sensitivity of water T2 obtained with IDEAL-CPMG in healthy and fat-infiltrated skeletal muscle by Sinclair, CD et al.
Received: 26 May 2016 Revised: 5 August 2016 Accepted: 29 August 2016DOI 10.1002/nbm.3654R E S E A R CH AR T I C L EStability and sensitivity of water T2 obtained with IDEAL‐CPMG
in healthy and fat‐infiltrated skeletal muscle
Christopher D.J. Sinclair1,2 | Jasper M. Morrow1 | Robert L. Janiczek3 |
Matthew R.B. Evans1 | Elham Rawah2 | Sachit Shah2 | Michael G. Hanna1 |
Mary M. Reilly1 | Tarek A. Yousry1,2 | John S. Thornton1,21UCL Institute of Neurology, MRC Centre for
Neuromuscular Diseases, London WC1N 3BG,
UK
2UCL Institute of Neurology, Neuroradiological
Academic Unit, London WC1N 3BG, UK
3GlaxoSmithKline, Uxbridge, UK
Correspondence
Christopher D. J. Sinclair, UCL Institute of
Neurology, MRC Centre for Neuromuscular
Diseases, London WC1N 3BG, UK.
Email: christopher.sinclair@ucl.ac.ukAbbreviations Used: ANOVA, analysis of variance;
coefficient of variation; CPMG, Carr–Purcell–Meibo
compartment; f.f., fat fraction; GRE, gradient echo; H
paralysis; IDEAL, iterative decomposition with echo
estimation; LG, lateral gastrocnemius; MG, medial
longus; ROI, region of interest; STIR, short‐tau in
anterior; S, soleus; s.d., standard deviation; TI, time t
This is an open access article under the terms of the
the original work is properly cited.
© 2016 The Authors. NMR in Biomedicine publishe
1800 wiQuantifying muscle water T2 (T2‐water) independently of intramuscular fat content is essential in
establishing T2‐water as an outcome measure for imminent new therapy trials in neuromuscular
diseases. IDEAL‐CPMG combines chemical shift fat–water separation with T2 relaxometry to obtain
such a measure. Here we evaluate the reproducibility and B1 sensitivity of IDEAL‐CPMG T2‐water
and fat fraction (f.f.) values in healthy subjects, and demonstrate the potential of the method to
quantify T2‐water variation in diseased muscle displaying varying degrees of fatty infiltration.
The calf muscles of 11 healthy individuals (40.5 ± 10.2 years) were scanned twice at 3 T with an
inter‐scan interval of 4 weeks using IDEAL‐CPMG, and 12 patients with hypokalemic periodic
paralysis (HypoPP) (42.3 ± 11.5 years) were also imaged. An exponential was fitted to the signal
decay of the separated water and fat components to determine T2‐water and the fat signal ampli-
tude muscle regions manually segmented.
Overall mean calf‐level muscle T2‐water in healthy subjects was 31.2 ± 2.0 ms, without significant
inter‐muscle differences (p = 0.37). Inter‐subject and inter‐scan coefficients of variation were 5.7%
and 3.2% respectively for T2‐water and 41.1% and 15.4% for f.f. Bland–Altman mean bias and ±95%
coefficients of repeatability were for T2‐water (0.15, −2.65, 2.95) ms and f.f. (−0.02, −1.99, 2.03)%.
There was no relationship between T2‐water (ρ = 0.16, p = 0.07) or f.f. (ρ = 0.03, p = 0.7761) and
B1 error or any correlation between T2‐water and f.f. in the healthy subjects (ρ = 0.07, p = 0.40).
In HypoPP there was a measurable relationship between T2‐water and f.f. (ρ = 0.59, p < 0.001).
IDEAL‐CPMG provides a feasible way to quantify T2‐water in muscle that is reproducible and
sensitive to meaningful physiological changes without post hoc modeling of the fat contribution.
In patients, IDEAL‐CPMG measured elevations in T2‐water and f.f. while showing a weak
relationship between these parameters, thus showing promise as a practical means of quantifying
muscle water in patient populations.
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The accurate quantification of muscle‐water transverse magnetiza-
tion relaxation time (T2) as a potential treatment‐trial outcome
measure is an important challenge.1 As trials of important newcense, which permits use, distribution and reproduction in any medium, provided
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SINCLAIR ET AL. 1801therapies in muscle diseases commence, there is a need for out-
come measures to quantify disease progression and treatment
effects that are more responsive than existing functional tests.2
Muscle fat infiltration and edema are both common pathological
manifestations in neuromuscular diseases, and may in principle
occur concurrently or independently; changes in muscle‐water T2
(T2‐water) may thus be hypothesized to occur prior to, independently
of, or in conjunction with muscle infiltration by fat. T2 measurement
methods that do not discriminate between fat and water signal
contributions yield a combined T2 value that has been termed the
global T2.
1 The T2 of fat is longer than T2‐water in healthy muscle,
and therefore, unless the fat and water signal contributions can
be separated, increased fat content and increased T2‐water both
elevate the apparent global T2, complicating the interpretation of
such a finding. Methods to obtain muscle T2‐water independently
of fat content are therefore needed in order to assess the
potential of T2‐water as a marker of disease progression or treat-
ment response providing pathological specificity beyond that that
provided by muscle‐fat measurement alone.
Conventionally, T2 is measured in MRI by collecting multiple
spin‐echo images and fitting the signal decay with echo time (TE)
to a theoretical model of the expected signal behavior. The respec-
tive independent contributions of fat and water to the decay signal
can be obtained by two approaches: by modifying the acquisition
sequence to provide selective relaxation‐time or chemical‐shift
based signal separation, where the fat signal is suppressed with
spectrally selective saturation or inversion recovery methods leaving
a signal that is dominated by the water component,3 or by
attempting to fit an appropriate multi‐component model to the
combined signal time course, assuming the measured signal is the
sum of two or more independent decay functions attributable to
water and fat.4,5 This latter method may be augmented by chemi-
cal‐shift fat–water signal separation techniques such as three‐point
Dixon imaging implemented in a separate additional acquisition,
providing an independent measurement of the fat–water ratio that
can be used to constrain a multi‐exponential fit to the non‐fat‐
suppressed spin‐echo decay.6 The IDEAL‐CPMG pulse sequence7
combines IDEAL (iterative decomposition with echo asymmetry
and least‐squares estimation) fat–water chemical shift separation8
with Carr–Purcell–Meiboom–Gill (CPMG) multi‐spin‐echo T2 mea-
surement, thus permitting independent measurements of T2‐water
and T2‐fat in a single acquisition.
To date, the feasibility of IDEAL‐CPMG muscle T2 relaxometry
has been demonstrated in five healthy volunteers and in a single
representative patient, with methodological validity evaluated
in vitro.7 Here we evaluate the performance of IDEAL‐CPMG T2‐
water relaxometry in healthy and diseased muscle. We present nor-
mative 3 T T2‐water values for calf‐level muscles, and assess in a
group of healthy adults scan–scan stability, and the relationship
between T2‐water estimates and transmit B1 variation. This relation-
ship is important because B1 variation has been identified as a major
determinant of T2‐water estimation accuracy in multi‐component
modeling of conventional CPMG data.4 Finally, in a cohort of patients
with hypokalemic periodic paralysis (HypoPP),9,10 a muscle ion
channelopathy causing periodic attacks of weakness in whichpatients present with a spectrum of both edematous and fatty‐muscle
pathology, the relationship between measured T2‐water and muscle fat
content is investigated to determine how effectively IDEAL‐CPMG
decouples T2‐water measurements as fat content varies.2 | METHODS
2.1 | Image acquisition
Both calves were imaged at 3 T (Siemens TIM Trio, Erlangen, Germany)
in a feet‐first supine position with surface matrix coils for signal recep-
tion. The IDEAL‐CPMG pulse sequence was implemented
(TR = 3000 ms, 3 × 5 mm slices, 10 mm gap, 192 × 96 matrix,
41 × 20.5 cm2 field of view (FOV)) with three gradient‐echo (GRE) shifts
at (−1.02, 0.61, 2.25) ms around each of 16 spin echoes with spin‐echo
times (TE) from 12 ms with a 12 ms interval with a bandwidth of
2003 Hz/pixel. The central slice was prescribed at a fixed distance of
15 cm below the knee joint in all cases. To independently assess muscle
T2‐weighted signal change patterns, short‐tau inversion recovery fat‐
suppressed (STIR) images (TR/TE/TI = 5500/56/220 ms, 9 × 10 mm
slices, 256 × 120 matrix) were also acquired. A high‐resolution GRE
image was acquired to provide a reference for muscle segmentation
(TR/TE = 100/3.45 ms, flip angle =10°, matrix 512 × 240, FOV
44 × 20.6 cm2). B1 maps were acquired with the double angle method
11
(TE/TR = 11/7000 ms, FOV 44 × 20.6 cm2, 40 × 10 mm slices, nominal
flip angles 60° and 120°), with B1 error expressed as the percentage
deviation of the actual flip angle from that nominally prescribed.
11 healthy volunteers (eight male, mean age ± standard deviation
(s.d.) 40.5 ± 10.2 y, range 26.5–61.3 y) with no known muscle
pathology were scanned at baseline (Scan A) and again after four
weeks (Scan B) (mean interval 27.4 ± 3.5 days) to assess the stability
of muscle T2 measurements. 12 HypoPP patients (nine male,
42.3 ± 11.5 y, range 23.2–58.5 y) were scanned once with the same
acquisition protocol as the healthy subjects. Inclusion criteria were
genetically confirmed diagnosis with mutations in the CACNA1S gene
or SCN4A gene and clinical evidence of active disease, with either
patient report of attacks of weakness, or progressive fixed weakness
on examination. Patients had a mean disease duration of 30.8 ± 11.4 y,
range 15–53 y. At the time of scanning, nine patients were on regular
medication, one patient on as‐required medication and two patients on
no medication for HypoPP. Most commonly used medications were
Sando‐K in eight patients and acetazolamide in five patients.2.2 | Data processing and analysis
Imaging data were exported from the scanner and processed offline
using the Python programming language (www.python.org) and
Wolfram Mathematica 10 (Champaign, IL, USA). A radiologist
performed manual muscle segmentation on the GRE images using
the ITK‐SNAP software,12 outlining six separate muscles (tibialis ante-
rior (TA), peroneus longus (PL), lateral gastrocnemius (LG), medial gas-
trocnemius (MG) and soleus (S), and a deep posterior compartment
(DP) (encompassing tibialis posterior, flexor digitorum longus and
flexor hallucis longus) in each limb at a single level on the middle slice
FIGURE 1 A, Example high‐resolution GRE image of a volunteer with muscle segmentations overlaid. B–F, The separation of water and fat with
IDEAL‐CPMG in a 53‐year old patient with HypoPP. B, B0 offset map obtained in the IDEAL decomposition. C,D, The raw signal is separated into
the water (C) and fat (D) components with the IDEAL algorithm to produce 16 such pairs of images for each spin echo. Mono‐exponential functions
are fitted to the signal decays. E, The T2 of the water component (T2‐water) is determined from the decay rate of the signal fitted to the water
component. F, The f.f. is calculated as the ratio of the fitted proton‐density amplitudes at t = 0. G, The χ2 goodness of fit for the water component.
H, The B1‐error map
1802 SINCLAIR ET AL.(Figure 1A)), excluding major vessels and nerves. The segmentations
were resampled to match the IDEAL‐CPMG acquisition matrix and
the borders eroded to reduce contamination from subcutaneous fat
at the region of interest (ROI) edges. The IDEAL fat–water separation
algorithm was implemented13 with the NumPy Python package, using
a seven‐peak model of the fat spectrum7 to derive fat and water‐only
images for each spin echo, and a map of static field (B0) variation.To estimate tissue T2 values and proton densities, mono‐
exponential decay functions were fitted to the fat and water signals
separately using a least‐squares Levenberg–Marquardt algorithm. In
all cases the first echo was excluded from the fit to ensure consistent
stimulated‐echo coherence contributions. The amplitude (A), T2 and
signal offset (c) were determined for the water (w) and fat (f) compo-
nents respectively on a pixel‐wise basis by fitting to the function
SINCLAIR ET AL. 1803S =A exp (‐t/T2) + c. The unreduced χ2 sum of squares was used to
assess goodness of fit.
To determine the fat to MRI‐visible proton‐density ratio (apparent
f.f.) the sum of the total signal extrapolated to TE = 0 was used in order
to minimize T2‐weighting bias
7 such that f.f. = Af/(Aw + Af).
The Scan A–Scan B reproducibility for the healthy subjects was
evaluated using the two s.d. limits of agreement and intra‐class
correlation coefficients, with signed rank tests for paired comparisons.
The individual source data points for this analysis were obtained as the
ROI mean of each muscle segmentation applied to the respective
IDEAL‐CPMG T2 maps. Coefficients of variation (CoVs) were
calculated according to Reference 14. Inter‐muscle variation was inves-
tigated by analysis of variance (ANOVA) with a significance level of
0.05. Left–right differences in B1 were compared on a muscle‐wise
basis with paired t‐tests. The relationship between T2‐water and f.f.
was evaluated with Spearman rank coefficients, with p < 0.05 consid-
ered significant. Patient–control group differences were evaluated
using the Mann–Whitney test.3 | RESULTS
3.1 | IDEAL‐CPMG fat–water separation and fitting
IDEAL‐CPMG successfully separated the water and fat signal for each
spin echo. Examples of IDEAL‐CPMG fat–water separation and fitting
are shown in Figure 1. The B0 map derived from the IDEAL algorithm is
shown in Figure 1B, with the accompanying water and fat separated
images in Figure 1C,D respectively. Figure 1E,F shows the derived
T2‐water and f.f. maps for this subject. Figure 1G,H shows the χ
2
map for the water component and the B1‐error map respectively.FIGURE 2 Mono‐exponential fits and accompanying residual plots for the
ject and a patient. Fits are expressed as dashed lines. Insets denote the nat
signal and the fits are plotted in the panels beneath. The first sampled echo
A, water (Aw = 1020.5, T2w = 31.6 ms, cw = 8.1), fat (Af = 18.6, T2f = 200 ms
fat (Af = 279.4, T2f = 67.0 ms, c = 55.3) and f.f. = 35.4%Examples of mono‐exponential fits to the T2‐decay signals with
accompanying residual differences between the fits and the data are
shown in Figure 2 for representative single pixels in the soleus muscles
of a healthy subject with low muscle‐fat content, yielding f.f. of 1.8%
(Figure 2A), and a patient with f.f. of 35.4% (Figure 2B).3.2 | T2‐water and f.f. in healthy subjects
The healthy volunteer data are tabulated by muscle in Table 1. The
mean (±s.d.) T2‐water across all muscles in Scan A was 31.2 ± 2.0 ms.
ANOVA did not reveal any significant inter‐muscle differences
(p = 0.37). The greatest variance was observed in the lateral and medial
gastrocnemii muscles, attributable to two subjects displaying transient
elevated water content in these muscles.
Mean f.f. across all muscles in Scan A was 4.6 ± 1.9%. The
individual muscle with the highest mean f.f. was the PL, and that with
the lowest the TA (Table 1), with ANOVA indicating that inter‐muscle
f.f. differences were significant (p = 0.004).3.3 | Stability of T2‐water and f.f. measured in
healthy subjects
Table 1 gives theCoVs for inter‐subject and4week inter‐scan differences
for each muscle and for all muscles combined. T2‐water inter‐subject
variation was higher than the inter‐scan variation (5.7% compared with
3.2%). Similarly, inter‐subject f.f. variation (41.1%) was higher than the
inter‐scan variation (15.4%). Overall intra‐class correlation coefficients
for the 4 week scan differences were 0.70 (T2‐water) and 0.86 (f.f.),
with paired sign‐rank tests for 4 week differences non‐significant for
all muscles (p = 0.92 T2‐water and p = 0.12 f.f.) Bland–Altman plots
for all muscles are shown for (A) T2‐water and (B) f.f. in Figure 3 withwater and fat signals for a single pixel in the S muscle of a healthy sub-
ural logarithm of the data and fit. The residual differences between the
is not included in the fit optimization function. Fitted parameters were
, c = 1.9), f.f. = 1.8%, and B, water (Aw = 509.6, T2w = 33.1 ms, c = 10.8),
TABLE 1 The group mean and s.d. values for T2‐water and f.f. for each muscle examined in the healthy subjects. Scan A and Scan B denote the
4 week separated scans. Mean values across all muscles are given in the final row. CoVs for inter‐subject and inter‐scan differences are given
(expressed as a percentage of the respective mean value)
Muscle
T2‐water (ms) f.f. (%)
Mean CoV (%) Mean CoV (%)
Scan A Scan B Inter‐subject Inter‐scan Scan A Scan B Inter‐subject Inter‐scan
Right TA 30.4 ± 1.3 30.3 ± 1.0 3.7 1.3 3.8 ± 0.9 3.6 ± 1.0 24.5 10
Right PL 30.3 ± 0.9 30.5 ± 1.1 3.2 2.3 6.3 ± 1.5 6.2 ± 1.9 26.3 12.3
Right LG 31.8 ± 2.9 31.1 ± 2.0 7.9 4.8 5.1 ± 1.8 5.8 ± 2.4 41.0 26.2
Right MG 31.2 ± 2.2 30.4 ± 1.2 5.7 4.2 4.3 ± 1.2 4.2 ± 1.3 27.9 6.3
Right S 32.0 ± 1.1 32.0 ± 0.8 3.0 2.3 4.5 ± 1.5 4.3 ± 1.4 31.3 6.1
Right DP 31.3 ± 1.0 31.5 ± 1.2 3.4 2.0 4.0 ± 2.1 3.9 ± 1.7 45.7 16.7
Left TA 30.8 ± 0.7 31.1 ± 1.0 2.7 2.0 3.5 ± 1.0 3.5 ± 0.7 23.8 12.9
Left PL 30.3 ± 1.6 30.7 ± 1.9 5.7 2.6 5.8 ± 2.2 5.4 ± 2.0 35.1 10.5
Left LG 31.1 ± 3.3 30.4 ± 2.0 8.7 4.5 4.2 ± 1.4 5.1 ± 1.7 37.8 31.2
Left MG 31.6 ± 3.4 30.9 ± 2.3 9.0 4.1 5.4 ± 3.1 5.1 ± 2.8 53.3 8.9
Left S 31.5 ± 1.2 31.4 ± 1.0 3.3 2.7 4.5 ± 2.0 4.5 ± 2.0 44.1 7.1
Left DP 31.9 ± 0.9 32.0 ± 1.6 4.1 2.8 3.7 ± 1.3 3.3 ± 1.1 32.3 14.4
Mean all muscles 31.2 ± 2.0 31.0 ± 1.6 5.7 3.2 4.6 ± 1.9 4.6 ± 1.9 41.1 15.4
FIGURE 3 Bland–Altman plots for 4 week
repeat measurements (Scans A and B) of T2‐
water and f.f. in the healthy subjects. Dashed
lines represent the mean bias and ±2 s.d. limits
of agreement (0.15, −2.65, 2.95) ms and (0.02,
−1.99, 2.03)% respectively. Symbols represent
the individual muscles. No systematic cluster-
ing by muscle can be observed
1804 SINCLAIR ET AL.respective mean bias and limits of agreement of (0.15, −2.65, 2.95) ms
and (−0.02, −1.99, 2.26)% depicted by dashed lines.
Figure 4 shows a healthy individual at Scan A and Scan B,
demonstrating an initially elevated right MG T2‐water (Figure 4A)
that had returned to a normal level after 4 weeks (Figure 4D).
There was no appreciable change in f.f. (Figure 4B,E), while MG
and LG muscle STIR image hyper‐intensity at Scan A (Figure 4C)
corroborates the presence of true water‐related changes in this
muscle at that time.3.4 | T2‐water versus f.f. in healthy subjects
Mean muscle T2‐water is plotted against f.f. for each muscle in the
healthy subjects in Figure 5. There was no significant correlation
between T2‐water and f.f. (Spearman’s ρ =0.07, p = 0.40).
3.5 | Influence of B1 transmit homogeneity
An example of a B1‐error map in a healthy subject is shown in
Figure 6A, with the B1‐error color‐scale range of −20 to +40%
FIGURE 4 Elevated T2‐water in the gastrocnemius muscles of a healthy subject. A, The T2‐water map displays elevated values in the LG and MG
muscles (white arrow). B,C, The f.f. map does not display any abnormality (B) but the STIR images confirm the genuine fluid changes (C). D–F, After
4 weeks the region of elevated T2‐water (D) has decreased, with corresponding f.f. map (E) and STIR image (F)
FIGURE 5 T2‐water plotted against IDEAL f.f.
for the 11 healthy subjects (Scan A). Symbols
denote the muscle ROI. There is no linear
gradient denoting a relationship between f.f.
and T2‐water in these subjects
SINCLAIR ET AL. 1805chosen to emphasize B1 deviation across the image. T2‐water signal
decays are shown for two different pixel regions in Figure 6B,C,
denoted by asterisks in Figure 6A. The relationship between ROI‐
mean T2‐water and B1 error is plotted for all healthy subject ROIs in
Figure 6D and between f.f. and B1 error in Figure 6E on a muscle‐
by‐muscle basis. There was no relationship between T2‐water and B1
error (Spearman’s ρ 0.16, p = 0.07) and no significant correlation
between f.f. and B1 error (Spearman’s ρ 0.03, p = 0.77).3.6 | T2‐water versus f.f. in HypoPP patients
The overall mean T2‐water and f.f. in the HypoPP patient group were
34.5 ± 6.6 ms and 14.7 ± 16.9% respectively, and both were elevated
compared with the healthy volunteer group (p < 0.001). ROI mean T2‐
water and f.f. are given for the left‐limb individual muscles of the 12
patients in Table 2. ANOVA did not indicate significant inter‐muscle
differences for T2‐water (p = 0.40) or f.f. (p = 0.38).3.7 | Relationship between T2‐water and f.f. in patients
A plot of individual muscle ROI mean T2‐water versus f.f. is shown for
the patient group in Figure 7, where there was a greater spread of both
T2‐water and f.f. (Table 2) than in healthy volunteers. The equivalent
correlations, gradients and intercepts were (ρ = 0.59, p < 0.001),0.31 ms/% (95% confidence interval (C.I.) 0.26–0.36 ms/%) and
30.3 ms (95% C.I. 29.3–31.3 ms) respectively. Figure 7B shows the
same data as in A in the range 0–15% f.f.
Figure 8 shows individual pixel plots to illustrate how the range of
scatter in Figure 7 arises from the behavior in given individual muscles,
demonstrating the pixel‐level relationship between T2‐water and f.f. in
a number of different conditions. Figure 8A,B shows healthy volunteer
S and MG muscles respectively where no (A) and moderate (B) T2‐
water elevations are observed without corresponding increase in mea-
sured f.f. In Figure 8C there are substantial increases in f.f. of the PL
muscle of a HypoPP patient while the T2‐water values remain in the
normal range. In the LG muscle of the HypoPP patient in Figure 8D,
both quantities are elevated in a heterogeneous manner.4 | DISCUSSION
In this work we aimed to address practical and technical considerations
concerning the use of IDEAL‐CPMG to quantify the T2 of muscle water
in the presence of fat infiltration, and demonstrate the sensitivity of
the measurements in a group of healthy subjects and in a representa-
tive disease. We observe that IDEAL‐CPMG imaging provides stable
measures of calf‐level muscle T2‐water in repeated measurements in
healthy individuals (Figure 3 and Table 1), with sufficient sensitivity
FIGURE 6 A, Example B1‐error map in a
healthy subject, scaled to the range of −20 to
+40% deviation from the prescribed flip angle.
B,C, T2‐water signal for the pixels in different
B1 regions denoted by the asterisks in A,
yielding fits of Aw = 1104.5, T2w = 32.6 ms,
cw = 16.1 and Aw = 782.0, T2w = 32.4 ms,
cw = 4.2 respectively. D,E, The mean T2‐water
and f.f. against B1 error for each muscle in the
healthy subjects. Spearman’s rank coefficients
were non‐significant, indicating that there was
no measurable relationship between these
measured quantitative parameters and B1
1806 SINCLAIR ET AL.to detect minor T2 elevations, even in healthy subjects (Figure 4) and
without correlation with transmit field B1 inhomogeneity (Figure 6).
The method can determine T2‐water in a variety of muscle tissue
states. In terms of muscle ROI mean values, at low f.f. levels T2‐water
is not influenced by fat infiltration in either healthy subjects or patients
(Figure 5, Figure 7). When fat is present in greater quantities in
patients, mean muscle T2‐water is elevated in some cases (Figure 7).At the individual pixel level, a range of scenarios of T2‐water and f.f.
relationships can be discriminated, as illustrated by the pixel‐wise plots
in individual muscles (Figure 8), which may contribute to the observed
overall ROI mean effects.
There is an important need to be able to quantify the water com-
ponent of muscle in neuromuscular conditions, which this work aims to
address. Effective muscle water T2 measurement is a valuable tool for
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SINCLAIR ET AL. 1807probing normal muscle functional physiology and for tracking disease
processes, which may be amenable to therapeutic intervention. It is
well known that exercise challenges elevate the MRI‐visible water load
in normal muscle.15 In conditions where the normal function of muscle
is affected by molecular dystrophic deficiencies16 or deficiencies in ion
channel transport,17 water changes such as edema and inflammation
are important markers of disease activity. Crucially, these can occur
before significant fat infiltration or atrophy is present, and alterations
in water load may offer markers indicating successful application of a
therapy to its target. Indeed, for novel therapies that may involve exer-
cise itself,18 quantifying such muscle changes under these circum-
stances is essential. Therefore methods to detect water changes
sensitively at an early stage by quantifying T2, in early disease and then
progressively as fat begins to encroach simultaneously with evolving
water changes, have been receiving increased attention. This work
evaluates IDEAL‐CPMG as a practical method for measuring muscle
water T2 in the presence of fat.4.1 | T2‐water and f.f. in healthy subjects
The mean T2‐water obtained in healthy lower‐limb muscles,
31.2 ± 2.0 ms, was consistent with values recently reported in other
3 T studies using different strategies to obtain fat‐independent T2‐
water in thigh muscles,19,20 and with a 32 ms‐centered T2 component
observed in the soleus muscle from a localized 1000 TE CPMG acqui-
sition.21 Using standard non‐fat‐suppressed CPMG MRI, Forbes
et al.22 reported a soleus T2 of 32.2 ± 1.9 ms in healthy boys, compared
with a slightly lower value (28.1 ± 0.81 ms) using a spectrally resolved
multi‐echo MRS method.
The distribution of T2‐water values in healthy subjects was low
compared with plausible increases due to disease (Table 2), indicating
that small pathological perturbations should be readily detectable with
IDEAL‐CPMG. In circumstances of disease or exercise‐driven T2‐water
changes, defining the normal range as 1.96 s.d. around the mean would
imply an upper threshold of 35.1 ms for overall T2‐water abnormality.
The pattern of highest f.f. in PL and lowest f.f. in TA is consistent with
previously reported patterns.23,244.2 | Stability and sensitivity in healthy subjects
An important property of any quantitative method is good reproduc-
ibility under typical clinical acquisition conditions, which we assessed
here by repeat scanning of healthy subjects at a 4 week interval. The
overall indices of reproducibility in healthy subjects were high
(indicated by the Bland–Altman limits of agreement (Figure 3) and
CoVs (Table 1). Moreover, sensitivity was sufficient to observe a gen-
uine serendipitous change in T2‐water in isolated muscles in a healthy
subject over a 4 week period (Figure 4). The origin of these changes is
not clear, although transient sequelae of a physical exertion, resolved
over the timescale of weeks, seem a likely cause. Importantly, refer-
ence to qualitative normalized STIR images corroborated these
changes, providing independent qualitative verification of T2‐water
elevations representing and quantifying genuine fluid‐driven effects
in this healthy individual. The sensitivity of IDEAL‐CPMG to detect
small T2‐water changes such as those associated with everyday activity
FIGURE 7 A, Mean T2‐water plotted against
mean f.f. for all muscle ROIs in the HypoPP
patients. B, The same data plotted in the range
0–15% f.f. There are examples of highly ele-
vated f.f. without corresponding T2‐water
elevation and cases where both are elevated
simultaneously
FIGURE 8 Pixelwise plots of T2‐water versus f.f. in individual subjects. A, Plot of pixel values in the left soleus muscle of a healthy subject that dis-
plays neither T2‐water nor f.f. elevation. B, Pixel values in the right MG muscle in a healthy subject illustrating elevation of T2‐water without sub-
stantial fat infiltration. C, f.f. in the PL muscle in a HypoPP patient is substantially elevated while T2‐water values remain within the normal range. D,
Both T2‐water and f.f. are elevated in the left LG muscle of a HypoPP patient. White arrows indicate the respective muscle plotted in each case
1808 SINCLAIR ET AL.is an important advantage, and highlights the need to control for
such factors in patient studies where both pathology‐ and everyday‐
activity‐related effects may induce parallel T2‐water changes.
When assessing the stability of T2‐water measurements, it is instruc-
tive to consider the changes expected due to disease, exercise or injury.
In the case of changes expected in disease, mean skeletal muscle T2‐
water increases between patient and control groups have been reportedto be around 10–15% in Duchenne muscular dystrophy25,26,22 and
Pompe disease.27 Themetabolic sequelae of exercise immediately before
measurement may increase muscle T2 by around 5 ms (16%),
28 with
recovery within 45 minutes to baseline values.29 Eccentric exercise of
sufficient intensity to result in muscle injury causes longer‐term T2
changes, with for example a 2 ms increase detectable after 24 h,30 rising
to a peak value up to 20 ms above baseline 3–5 days after injury.31
SINCLAIR ET AL. 18094.3 | B1 insensitivity
A common finding in quantitative MRI is errors arising under non‐ideal
measurement conditions such as static or RF magnetic field homoge-
neity. Such errors must be understood or corrected to permit proper
interpretation of observed variations. In this work we used the double
angle method to measure the B1‐transmit RF inhomogeneity. The B1
variation (Figure 6A) over the imaging slice was marked, and typical
of that commonly observed in calf muscles using conventional circu-
larly polarized transmission at 3 T.32 However, our T2‐water and f.f.
measurements did not demonstrate any significant dependence on
B1 error (Figure 6D,E), indicating for the first time that the
IDEAL‐CPMG method is fairly robust to the influence of transmit field
variation. This is in contrast to findings reported when fitting multi‐
exponential functions to non‐fat‐suppressed CPMG data that may be
to some extent influenced by B1,
4 and may represent a major
advantage of IDEAL‐CPMG in this context. This may in part be a con-
sequence of the performance of IDEAL fat–water separation being to a
large extent independent of B1‐driven source‐image amplitude varia-
tions, whereas methods dependent on estimating both fat and water
amplitudes, as well as their respective T2 values, by fitting a single
multi‐component model to a combined CPMG decay signal, may result
in both B1‐dependent apparent f.f. and T2 errors. The IDEAL‐CPMG
approach may compliment other recently reported methods with
reduced sensitivity to B1 effects by implicitly including B1 field in a
multi‐parameter extended phase graph modeling of the signal decay.204.4 | Measurements in HypoPP
The HypoPP patient group showed statistically elevated T2‐water
compared with healthy subjects, as well as f.f. elevation (Table 1,
Table 2), supporting the value of IDEAL‐CPMG muscle T2 as an index
of pathology in this condition. 23.6% of the patient ROI mean T2‐water
values were outside the 1.96 s.d. range of the healthy volunteers. The
majority of the group mean muscle values in the HypoPP group,
although elevated, were therefore not outside the range of normality.
Although not observed in our data set, sensitivity to reductions in
T2‐water may also be important in other neuromuscular conditions,
particularly in the light of recent reports that measured T2 may in fact
decrease in Duchenne muscular dystrophy.23,24
HypoPP is an autonomic dominant disorder associated with
mutations in the CACNA1S or SCN4A genes causing periodic serum
potassium changes and muscle weakness without myotonia.9 The
effect of treatment with acetazolamide over 4 weeks has been previ-
ously measured using STIR imaging.33 Fat‐suppressed T2‐weighted
imaging has previously been used to investigate imaging characteristics
in a group of Asian subjects with HypoPP and healthy controls before
and after exercise.34 These reports of T2‐weighted contrast changes
suggest that the ability to quantify T2 changes in HypoPP may provide
an important tool for monitoring this condition.4.5 | Measuring T2‐water in the presence of fat
In skeletal muscle, myocellular fat replacement and changes in the
intra‐ and extra‐myocellular water distribution can hypothetically
occur independently or simultaneously within a tissue volumedepending on the underlying disease process. There is no a priori
assurance that a region of muscle displaying substantive fat infiltration
will not also exhibit simultaneous related or independent water‐driven
T2 changes. Indeed it seems probable that a given tissue volume under-
going active pathological processes is likely to encompass a spectrum
of simultaneously evolving T2‐influencing features, both fat and water
based. This should be considered when assessing the effectiveness of
any technique that aims to measure T2‐water prolongation indepen-
dently of fat, because the scenario of absolute independence may
often be hypothetical; apparently associated T2‐water and f.f. increases
may reflect genuine T2‐water elevation temporally correlated with f.f.
as two facets of disease progression with physically distinct substrates.
This is a situation in direct contrast to the apparent coupling of tissue
T2 and f.f. obtained in a non‐separated global T2 measurement.
The relationship between mean muscle T2‐water and f.f. is shown
for each of 12 muscles in the 12 patients in Figure 7, and for illustrative
pixel‐wise examples in individual muscles in Figure 8. When f.f. is
elevated (>5%), there are examples where T2‐water remains close to
normal values (e.g. Figure 8C) and others where the T2‐water is sub-
stantially elevated (Figure 8B,D). Despite the range of physical scenar-
ios presented in Figure 8, it is nonetheless conceivable that incomplete
decoupling of water and fat could still be present to some extent due
to residual T1 or T2 weighting or an inadequate model for the fat
spectrum. In addition, since the apparent f.f. is strictly the fat–water
ratio determined by the fitted amplitudes Aw and Af, any coupling
between Aw and T2‐water will also contribute to bias in the f.f.–T2‐
water relationship. It is not typical to find a neuromuscular disease
model where either fat or water changes occur definitively in isolation
of each other that would allow these scenarios to be fully tested,
although further investigation of exercise‐based water changes in
healthy subjects may provide further insight.4.6 | Alternative methods to determine T2‐water
Imaging methods that measure T2‐water while accounting for concur-
rent fat infiltration are predominantly based either on post hoc
numerical modeling or on attempts to eliminate the fat signal at the
point of acquisition. For numerical stability, post hoc processing usually
requires an independent measure of the f.f., or a priori fat T2 values, to
constrain the amplitudes of multi‐exponential fitting of the raw decay
signal or by investigating multi‐exponential models with some fit
parameters fixed based on an understanding of the system. Recently
Marty et al. have successfully used a full extended phase graph
approach to obtain T2‐water fitting to a more comprehensive model.
20
Fat suppression techniques at the point of acquisition include several
varieties of spectral fat pre‐saturation of multi‐echo T2‐weighted
sequences. In contrast, in IDEAL‐CPMG the acquisition pulse
sequence is designed to acquire separate T2‐decay signals at several
GRE phase‐shifts so that chemical‐shift fat–water separation can be
used to decouple the fat and water signals in post‐processing, allowing
the fat and water signal decays to be captured independently in a sin-
gle acquisition. Indeed, the fat signal can be discarded if quantifying
water T2 is the primary interest.
Previous treatments of composite T2‐decay signals have in most
cases considered these to comprise a linear sum of mono‐exponential
1810 SINCLAIR ET AL.decay functions representing water and various triglyceride lipid spec-
tral components. When the water signal is available in isolation, as it is
here, it is important to be confident that a mono‐exponential T2‐decay
description is appropriate. The example mono‐exponential decay
functions fitted to the representative single pixel data in Figure 2
described the signal well. However, no attempt was made in this work
to establish a meaningful description of the time‐domain behavior of
the fat signal. Rather, a pragmatic approach was used to estimate the
proton‐density at t = 0 by fitting a mono‐exponential function to the
fat signal decay. The spectrum of fat has multiple components,35 each
with a different characteristic decay time.4 The dominance of a long
T2‐decay component, which is often observed in the fat signal decay,
is most likely ascribable to the large constant offset cf. For the current
purpose, an exponential function allows determination of the y‐axis
crossing Af in order to estimate the fat–water proportion with minimal
bias due to T2 weighting.
Volume‐localized MRS may also be a useful tool to obtain T2‐
water unambiguously separated from lipid resonance signals, and
future work correlating MRS and IDEAL‐CPMG findings may shed light
on the origin of elevated muscle water T2 in the presence of fat.4.7 | Considerations for IDEAL‐CPMG
implementation
A key advantage of IDEAL‐CPMG is that the f.f. and T2‐water are
obtained in the same acquisition. Although obtaining fat–water ratios
from a separate acquisition has been demonstrated to provide an
effective way to constrain multi‐component fits,6 in contrast IDEAL‐
CPMG does not require an alignment or registration step to ensure
that fat and water pixels coincide, a process vulnerable to error due
to subject motion or misalignment.
In common with most full CPMG‐based acquisitions, the slice
coverage achieved in a given repetition time is limited by the long echo
train and the consequent overall burden of RF energy absorption. The
in‐slice spatial resolution is also limited for the same reasons, and the
requirement to fit multiple GREs in the IDEAL‐CPMG implementation
imposes further constraints. Nonetheless, this approach allows an
overall survey of the muscle bulk at multiple levels with sufficient spa-
tial resolution to quantitatively assess patterns of fat and fluid infiltra-
tion in all key lower‐limb muscles (Figure 1). 2D or 3D three‐point
Dixon acquisitions may be better suited for specific measurements of
f.f. where high spatial resolution is required, but IDEAL‐CPMG is
unique in permitting both T2‐water and co‐localized f.f. determination,
albeit at the cost of lower coverage.
The relatively low spatial resolution and restricted anatomical
coverage in terms of the number of slices attainable within a rea-
sonable TR are a potential limitation of the current implementation
of the method. While these restrictions may be mitigated to a cer-
tain extent in the future by implementing further acceleration
methods, they are likely to limit applications requiring high spatial
resolution, such as in the pediatric population. Nevertheless, numer-
ous studies have successfully demonstrated the responsiveness of
MRI biomarkers in neuromuscular diseases with analyses based on
large ROIs, or whole muscle cross‐section means, from only a single
slice.The acquisition bandwidth is necessarily higher in IDEAL‐CPMG
than in standard CPMG acquisitions, resulting in decreased signal to
noise using this method. The SNR in the left soleus muscle in the
first GRE measured about the first spin echo was in the range 50–
100. Standard CPMG acquisitions are capable of yielding substan-
tially higher SNR, and this should be taken into consideration when
evaluating the suitability of this method. While there was no evi-
dence in the data we present of any clear relationship between
regional SNR and precision of the T2‐water estimate, for acquisitions
with substantially lower SNR this aspect may become an important
consideration.
To improve the quality of the separation and fitting itself, further
improvements may be possible. Clearly, stimulated echoes and
coherences manifest as periodic oscillations are visible in the water
signal (e.g. residuals in Figure 2), and these are not taken into
account in the mono‐exponential fitting process that discards the
first echo. There are strategies available to more fully model the
signal behavior based on knowledge of the slice RF profile.36,20 This
approach could be applied here and may improve the precision of
the fitted T2 (or f.f. via a more precise estimation of the amplitudes
Aw, Af, cw and cf). A seven‐peak model of the fat spectrum was used
in the IDEAL separation, with spectral components determined from
the literature. There may be opportunity to refine the parameters of
the spectral model further by acquiring custom spectra to more pre-
cisely define the frequency and relative amplitudes of the spectral
components.5 | CONCLUSION
Practical and efficient quantitative MRI protocols for tracking muscle
pathologies are urgently required. Trials of recently available genetic
and stem‐cell‐based experimental therapies for conditions such as
Duchenne muscular dystrophy37 demand outcome measures with
far greater responsiveness to temporal changes than any existing
clinical measures of strength or function. In the range of neuromus-
cular diseases, inflammation, edema, fat and fibrosis are the com-
mon mechanisms that can be identified on ex vivo pathology and
that give rise to the clinical deficit in muscle strength and function.
The challenge in this field is to track these changes directly, sensi-
tively, in vivo and repeatedly over time to unequivocally determine
the statistical efficacy of experimental treatments in cohorts of a
realistic size. Finding appropriate ways to use MRI to effectively
quantify muscle fibrosis remains an unsolved problem. However,
tracking water and fat changes is more immediately tractable and
much work has been conducted to date to demonstrate the suitabil-
ity of chemical‐shift‐based fat quantification in this context.38
Methods have also been proposed to measure water changes in
the presence of fat, a challenge that IDEAL‐CPMG addresses
directly.
In this work the reliability of IDEAL‐CPMG was demonstrated in
healthy individuals, and pathological sensitivity examined in a group
with HypoPP, a condition where muscle fluid and fat changes are both
present. The method was shown to be capable of reproducibly measur-
ing T2‐water in healthy subjects and identifying T2 elevations
SINCLAIR ET AL. 1811independently of fat in HypoPP patients, with general insensitivity to
transmit field variations. In HypoPP, and in other conditions where
water‐driven pathologies are important, IDEAL‐CPMG offers an
effective acquisition‐based approach to quantifying muscle water T2
independently of fat. The longitudinal responsiveness of T2‐water
thus obtained as a marker of disease progression, and the compara-
tive time courses of muscle f.f. and T2‐water changes, are now impor-
tant avenues of research.
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